p14ARF/CDKN2A Antibody, Novus Biologicals™

Rabbit Polyclonal Antibody

Supplier:  Novus Biologicals NB11059085SS

Catalog No. NB11059085T

Description

p14ARF/CDKN2A Polyclonal specifically detects p14ARF/CDKN2A in Human samples. It is validated for Western Blot.

Specifications

• Antigen: p14ARF/CDKN2A
• Classification: Polyclonal
• Conjugate: Unconjugated
• Formulation: Tris-Glycine and 0.15M NaCl with 0.05% Sodium Azide
• Gene Alias: ARF, CDK4 inhibitor p16-INK4, CDK4IP14ARF, CDKN2, cell cycle negative regulator beta, CMM2P16-INK4A, Cyclin-dependent kinase 4 inhibitor A, cyclin-dependent kinase inhibitor 2A, cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4), INK4, INK4A, MLMP16INK4, MTS-1, MTS1P14, Multiple tumor suppressor 1, p14, p14ARF, P16, p16-INK4, p16-INK4a, P16INK4A, P19, p19Arf, TP16
• Host Species: Rabbit
• Molecular Weight of Antigen: 16 kDa
• Quantity: 0.025 mL
• Research Discipline: Cancer, Cell Biology, Cell Cycle and Replication, Chromatin Research, Transcription Factors and Regulators, Tumor Suppressors
• Gene ID (Entrez): 1029
• Content And Storage: Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.

• Applications: Western Blot
• Concentration: 2.5 mg/mL
• Dilution: Western Blot 2 ug/ml
• Gene Accession No.: Q8N726
• Gene Symbols: CDKN2A
• Immunogen: A synthetic peptide made to a portion of human p14ARF (between residues 100-173). [Swiss-Prot# Q8N726]
• Purification Method: Affinity Purified
• Regulatory Status: RUO
• Primary or Secondary: Primary
• Target Species: Human
• Isotype: IgG

For Research Use Only